We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Anna MacDonald

Anna MacDonald

Science Writer

Contact Us

After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.

Latest Content
Industry Insight

Cell Culture: Moving from 2D to 3D and Beyond

To learn about the limitations of 2D cell culture models, the range of 3D tools available, and some of the advantages they can bring to researchers, we spoke to Dr. Richard Eglen, Vice President and General Manager of Corning Life Sciences.

Developing Innovative Biomaterials

Recipient of this year's Clemson Award for Contributions to the Literature, Dr. Khademhosseini tells us a little about his career and the work his lab is doing to develop innovative biomaterials that can help address a variety of biomedical challenges.
Industry Insight

Driving Forward Companion Diagnostics Development

We spoke to Dr. Markus Tolnay and Mark Stevenson, to learn more about the NGS Companion Dx Center of Excellence Program and what it hopes to achieve.

Organs-on-Chips: Applications, Challenges, and the Future

Limitations of current planar, static cell culture systems or animal models highlight the urgent need for more physiologically relevant models of human organs, and have fuelled the development of organs-on-chips.

Flow Cytometry: Future Opportunities and Current Cell Biology Applications

Learn more about flow cytometry including how it works, the market overview, applications in cell biology and health, and the future.

Mass Spectrometry in the Clinic

Here we take a look at some of the clinical applications that mass spectrometry currently plays a role in, and where the technology could be headed.
Industry Insight

The Role of Metabolomics in Diagnostics

We spoke to Volker Pfahlert, numares AG, to learn about the role of metabolomics in diagnostics and the advantages it can offer over current methods.

EVATAR - A Female Reproductive Tract on a Chip

We spoke to Dr. J. Julie Kim, Northwestern University, to learn more about the EVATAR project and how it could help the future of drug discovery and personalized medicine.

Stem Cells in Drug Discovery

We explore some of the roles of stem cells in drug discovery and the hurdles that researchers using them face.
Industry Insight

Improving Prostate & Bladder Cancer Diagnosis

We spoke to Nadia Whittley, CEO, Arquer Diagnostics, to learn about some of the current limitations of diagnosing bladder and prostate cancer, and how MCM5-ELISA tests could help.